Edition:
United Kingdom

Insider Trading: AxoGen Inc (AXGN.OQ)

AXGN.OQ on NASDAQ Stock Exchange Capital Market

21.01USD
9:00pm BST
Change (% chg)

$-0.59 (-2.73%)
Prev Close
$21.60
Open
$21.31
Day's High
$21.36
Day's Low
$20.74
Volume
86,841
Avg. Vol
171,116
52-wk High
$56.75
52-wk Low
$14.13

All Insider Trades
Trading Date Name Title Type Shares Traded Price
13 May 2019

Hansen David K

Officer and Treasurer Sell 20,000 $22.63
15 Feb 2019

Friedman (Mark Louis)

Officer Sell 573 $17.57
15 Feb 2019

Freitag (Gregory Gene Esq., J.D., CPA)

General Counsel Buy 3,377 $17.57
15 Feb 2019

Hansen David K

Officer and Treasurer Buy 1,930 $0.00
15 Feb 2019

Gingrich (Jon S.)

Officer Sell 1,342 $17.57
15 Feb 2019

Donovan (Michael Patrick)

Officer Buy 1,930 $0.00
15 Feb 2019

Mariani (Peter J)

Chief Financial Officer Sell 2,355 $17.57
15 Feb 2019

Mariani (Peter J)

Chief Financial Officer Buy 7,654 $0.00
15 Feb 2019

Hansen David K

Officer and Treasurer Sell 573 $17.57
15 Feb 2019

Devinney (Erick Wayne)

Officer Buy 5,079 $0.00
15 Feb 2019

Devinney (Erick Wayne)

Officer Sell 1,498 $17.57
15 Feb 2019

Gingrich (Jon S.)

Officer Buy 3,859 $0.00
15 Feb 2019

Friedman (Mark Louis)

Officer Buy 1,930 $0.00
15 Feb 2019

Donovan (Michael Patrick)

Officer Sell 573 $17.57
15 Feb 2019

Zaderej (Karen L)

Chief Executive Officer Buy 16,015 $17.57
30 Nov 2018

Freitag (Gregory Gene Esq., J.D., CPA)

General Counsel Sell 45,000 $33.00
19 Nov 2018

Zaderej (Karen L)

Chief Executive Officer Buy 30,000 $2.74
19 Nov 2018

Zaderej (Karen L)

Chief Executive Officer Buy 70,000 $2.74
19 Nov 2018

Zaderej (Karen L)

Chief Executive Officer Sell 6,761 $28.37
15 Nov 2018

Freitag (Gregory Gene Esq., J.D., CPA)

General Counsel Sell 20,000 $32.25
14 Nov 2018

Zaderej (Karen L)

Chief Executive Officer Sell 12,000 $32.93
13 Nov 2018

Zaderej (Karen L)

Chief Executive Officer Sell 13,000 $33.42
13 Nov 2018

Devinney (Erick Wayne)

Officer Sell 2,882 $33.28
13 Nov 2018

Devinney (Erick Wayne)

Officer Buy 35,000 $2.74
13 Nov 2018

Devinney (Erick Wayne)

Officer Buy 274 $0.27

Institutional Holders

% Shares Owned: 86.88%
# of Holders: 199
Total Shares Held: 34,012,513
3 Mo. Net Change: -776,277
# New Positions: 40
# Closed Positions: 51
# Increased Positions: 90
# Reduced Positions: 104
# Net Buyers: -14

Officers & Directors

Name Age Since Current Position

Karen Zaderej

56 2018 Chairman of the Board, President, Chief Executive Officer

Peter Mariani

54 2016 Chief Financial Officer

Maria Martinez

50 2018 Chief Human Resource Officer

David Hansen

57 2017 Vice President - Finance, Treasurer

Mike Donovan

54 2015 Vice President - Operations

Kevin Leach

48 2016 Vice President - Marketing

Kaila Krum

2018 Vice President, Investor Relations and Corporate Development

Christopher Crisman

2019 Vice President - U.S. Sales

Erick DeVinney

43 2014 Vice President of Clinical and Translational Sciences

Mark Friedman

60 2011 Vice President - Regulatory and Quality

Angelo Scopelianos

2018 Vice President - Research & Development

Gregory Freitag

56 2018 General Counsel

Isabelle Billet

57 2018 Chief Strategy and Business Development Officer

Eric Sandberg

2019 Chief Commercial Officer

Amy Wendell

58 2018 Lead Independent Director

Quentin Blackford

39 2019 Director

Jamie Grooms

58 2018 Director

Alan Levine

2019 Director

Mark Gold

69 2011 Independent Director

Guido Neels

69 2016 Independent Director

Robert Rudelius

62 2011 Independent Director